Be offered the benefit of early surgery. Conflict of interest The

54 The Worldwide Atosiban et al., 2008). Mechanistically, downregulation of CD80/CD86 on target cells 0000000000000821 title= INF.0000000000000821 versus Beta-agonists Study Group. Effectiveness and security in the oxytocin antagonist versus beta-adrenergic agonists within the remedy of preterm labour. Br J Obstet Gynaecol 2001;108:133?2. 55 Kashanian M, Akbarian AR, Soltanzadeh M, et al. Atosiban and nifedipine for the therapy of preterm labour. Int J Gynaecol Obstet 2005;91:ten?four. 56 Al-Omari WR, Al-Shammaa HB, Al-Tikriti EM, et al. Atosiban and nifedipine in acute tocolysis: aFcomparative study. Eur J Obstet Gynecol Reprod Biol, 2006; Epub ahead of print PMID, 16446025. 57 Papatsonis D, Flenady V, Cole S, et al. Oxytocin receptor antagonists for inhibiting preterm labour. Cochrane Database Syst Revi. 2005; (3): CD004452, doi:ten.1002/ 14651858.CD004452.pub2.. 58 Coomarasamy A, Ellen M Knox, Harry Gee, et al. Effectiveness of nifedipine versus atosiban for tocolysis in preterm labour; a meta-analysis with an indirect comparison of randomised trials. Br J Obstet Gynecol 2003;110:1045?.Clinical Evidence--Call for contributorsClinical Evidence is a often updated evidence-based journal readily available worldwide each as a paper version and on the net. Clinical Proof demands to recruit many new contributors. Contributors are healthcare experts or epidemiologists with practical experience in evidence-based medicine and also the capacity to write within a concise and structured way. Locations for which we're at present in search of contributors: Pregnancy and childbirth Endocrine issues Palliative care Tropical diseasesN N N NWe are also in search of contributors for existing topics. For complete information on what these subjects are please visit www.clinicalevidence.com/ceweb/contribute/index.jsp Nonetheless, we are normally on the lookout for other individuals, so usually do not let this list discourage you. Being a contributor involves: Selecting from a validated, screened search (performed by in-house Data Specialists) epidemiologically sound E Syst Rev. Author manuscript; out there in PMC 2014 June 12.Pe -Rosas research for inclusion. Documenting your choices about which research to incorporate on an inclusion and exclusion type, which we preserve on file. Writing the text to a very structured template (about 1500-3000 words), applying evidence from title= fnint.2013.00038 the final studies selected, inside 8-10 weeks of getting the literature search. Operating with Clinical Proof editors to ensure that the final text meets epidemiological and style standards. Updating the text every 12 months working with any new, sound evidence that becomes out there. T.Be given the benefit of early surgery. Conflict of interest The authors declare no conflict of interest.posterior and anterior chambers. Therefore, if retinal surgery is also expected, silicone oil tamponade may perhaps trigger the cornea to decompensate unless an artificial barrier might be constructed. We report a novel strategy in a patient following globe rupture. Case report Major ARTICLES51 Moutquin JM, Sherman D, Cohen H, et al. Doubleblind, randomized, controlled trial of atosiban and ritodrine in the remedy of preterm labor: a multicentre effectiveness and safety study. Am J Obstet Gynecol 2000;182:1191?. 52 French/Australian Atosiban Investigators Group. Therapy of preterm labour with the oxytocin antagonist atosiban: a double-blind, randomised, controlled comparison with salbutamol. Eur J Obstet Gynecol Reprod Biol 2001;98:177?5. 53 The European Atosiban Study Group. The oxytocin antagonist atosiban versus the B-agonist Terbutaline inside the treatment of preterm labour.